An announcement from Mount Ridley Mines Limited ( ($AU:MRD) ) is now available. Mount Ridley Mines Limited has disclosed a change in director ...

Mount Ridley Mines has signed a material transfer agreement with US national laboratory Lawrence Livermore National Security to support its downstream processing strategy for critical minerals.

At the recent American Society of Hematology (ASH) meeting, researchers presented early data from a phase II study evaluating ...

BostonGene has won four awards in the Research & Development, Product Launches, and Innovation categories in the 2025 ...

Q4 2025 showcased the industry’s pivot toward precise biology, localised delivery, and earlier intervention – with multiple ...

Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions Stay ahead of the market ...

Highlighting that the ASX has ended the week on a positive note, eight of the sectors were in the green while just three were ...

Natera, Inc. , a global leader in cell-free DNA and precision medicine, today announced the publication of findings from the randomized, phase III CALGB (Alliance)/SWOG 80702 study in JAMA Oncology.

The GLOVe regimen, combining glofitamab, lenalidomide, and venetoclax, shows rapid and deep responses in high-risk MCL ...

The 2025 San Antonio Breast Cancer Symposium brought plenty of data and bold new ideas to the thousands of clinicians, ...

WBD presented a chronology of events and meetings that occurred, leading to its deal to sell Warner Bros. studios and HBO Max ...

– NXC-201 demonstrated a complete response (CR) rate of 75% (15/20) (at s/u IFE (-) level) by independent review committee – – In four out of five pending patients, MRD negativity in bone marrow ...